Lancet

Article	Citations
Moderna stalls on African vaccine manufacturing plans	10395
Tonsillectomy for recurrent tonsillitis: the NATTINA trial	3750
The acknowledgment of death	2473
Establishing equitable partnerships between the Global North and Global South	2311
Miriam Mutebi: transforming breast cancer care in Africa	1608
Human rights considerations are key when choosing a conference location	1345
Interpreting COVID-19 data from China: a call for caution	1334
Donald Bernard Longmore	1334
Does TRIANGLE take down transplantation in mantle cell lymphoma?	1329
Hypochondria, the ghost at medicine's feast	1328
From innovation to impact in cardiovascular disease	1269
A new drug for rare diseases: pozelimab for CHAPLE disease	1165
From disappointment to despair: USAID cuts to Myanmar's HIV services	1163
A just transition for antimicrobial resistance: planning for an equitable and sustainable future with antimicrobial resistance	1124
Department of Error	1115
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial	1115
May Edward Chinn: pioneer of early cancer detection	1113
Ronald Duncan Bradley	1048
High-dose dual-antibiotic loaded bone cement in patients undergoing hemiarthroplasty	1035
On the quantification of military violence in Gaza	1015
Hypertrophic cardiomyopathy secondary to hydroxychloroquine toxicity in a patient with rheumatoid arthritis	991
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial – Authors' reply	922
Considerations for the CHH–Lancet Commission on Health, Conflict, and Forced Displacement	897
Israel border closure denying health care to Gazans	874
Department of Error	866

TRiP(cast) score and thrombosis risk for lower limb immobilisation – Authors' reply	835
Natural or artificial menstrual cycle for frozen embryo transfer	828
Political courage needed to prevent the next pandemic	792
Hearing intervention and cognitive decline: the ACHIEVE trial	773
Thinking outside of the tin box	755
Primary health-care practices for deaf children should include early incorporation of a signed language	737
Beverly Malone: valuing diversity in nursing	731
Treatment of vulnerable atherosclerotic plaques: the PREVENT trial	708
Retraction: The first tissue-engineered airway transplantation: 5-year follow-up results	687
Repeat placental growth factor-based testing in women with suspected preterm pre-eclampsia (PARROT-2): a multicentre, parallel-group, superiority, randomised controlled trial	668
A high prostatic-specific antigen with a large pelvic mass indicates a prostatic cystadenocarcinoma	657
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?	653
Knowledge and attitudes towards organ donation among students at An-Najah National University: a cross-sectional study	649
Physicians in the digital age	631
End compulsory drug treatment in the Asia-Pacific region	626
Sexual abuse and exploitation at WHO: an erosion of trust	624
Unclear conclusions on SARS-CoV-2 elimination versus mitigation	595
Reaching net zero carbon emissions in health systems	594
Understanding the potential and pitfalls of digital phenotypes to measure population mental health and wellbeing	590
Population health outcomes in Nigeria compared with other west African countries, 1998–2019: a systematic analysis for the Global Burden of Disease Study	582
Pandemics and the tourism industry: who is in control?	570
Department of Error	569
Neglected tropical diseases: ending the neglect of populations	565
Cervical cancers avoided by HPV immunisation	565
Moving past the COVID-19 emergency in the USA	551
Calvarium indentations in multiple myeloma and CAR T-cell therapy	536
COVID-19 mRNA vaccination and myocarditis or pericarditis	532
Nafis Sadik	519
Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine	516
Morphine for Gaza? Limits of care during genocidal violence	507
Antibiotic treatment duration for bacteraemic pneumonia	501
CoronaVac efficacy data from Turkey – Authors' reply	500
Interferon shrinks spleen in pregnant patient with myeloproliferative neoplasm	490
Something good enough	482
Australia to introduce sweeping e-cigarette regulations	466
“I am disabled, it doesn’t mean I have no dignity”	464
An age of uncertainty: mental health in young people	461
Mirtazapine for agitation in dementia: moving forward	456
Offline: What have we done to medical students?	444
Characteristics of yoga providers and their sessions and students in the UK: a cross-sectional survey	441
Prominent skin folds of the scalp provide a superficial clue in acromegaly	437
Department of Error	434
How can engagement with political science and international relations for health be improved?	433
Offline: Political declarations—clichés and lies	431
Nigeria: health as a political prerequisite	428
Visa bureaucracy causing GPs to leave the UK	427
A fair day's wage for a fair day's work	420
Anatomy teaching, dissection, and dignity of the dead	414
Offline: Changing the argument for health	414
An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial	409

Department of Error	408
Visualising facial distortions in prosopometamorphopsia	405
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial	405
Preventing cancer: the only way forward	404
Threat level in the Gaza Strip: fatalities per 1000 person-years	401
Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial	400
Imagining alternative paths for WHO 75 years in	397
Remote haemodynamic monitoring in patients with heart failure – Authors' reply	394
Fluid retention and heart failure in the PRECISION trial – Authors' reply	391
Racial inequities in homicide rates: Black women in the USA	386
Department of Error	382
Department of Error	380
Gaining MOMENTUM against anaemic myelofibrosis	374
Routine immunisations: reversing the decline	369
Human rights and health: a story of justice, hope, and resilience	368
Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review	366
IMbrave050: the first step towards adjuvant therapy in hepatocellular carcinoma	364
Ophira Ginsburg: educating and empowering women with cancer	363
Lowitja O'Donoghue	356
Associations between parental smoking and teenage alcohol and drug use in the Growing Up in Ireland cohort study: a longitudinal observational study	355
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial – Authors' reply	353
WHO EMRO's initiative on economic sanctions: delayed but promising	349
Haemophilia	346
Considerations in boosting COVID-19 vaccine immune responses	341
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study	340
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)	339
Safety and efficacy of aspirin, unfractionated heparin, both, or neither during endovascular stroke treatment (MR CLEAN-MED): an open-label, multicentre, randomised controlled trial	337
Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials	336
Brazil to start widespread dengue vaccinations	334
To keep health as a unifying force, we must put resources into tackling health misinformation and disinformation	331
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind	331
Tom Beauchamp	327
A taste of your own medicine: the experience of a transplant	325
The road ahead for immediate kangaroo mother care in resource-constrained health systems	322
Pembrolizumab for locally advanced cervical cancer	321
Türkiye rocked by newborn care scandal	319
Iscalimab 600 mg: justified or excessive? – Authors' reply	319
Primary health care on the ballot in Australian election	319
Regional action needed to halt antimalarial drug resistance in Africa	316
Strikes	316
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China	311
Legal accountability for climate change	311
Jenna Lester: advancing diversity in dermatology	306
Tackling heroin use in Mozambique	298
Lower respiratory tract infections in early childhood	297
HPV vaccination and cervical cancer screening	292
A decolonised Commission agenda: the missing ingredients	291
Omicron: fewer adverse outcomes come with new dangers	290
Health at stake in Kenya elections	289
Protecting children from racism: urgent health system actions	289
The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation	288
Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis	288
Key questions regarding the SYMPLICITY HTN-3 trial	286
Sackler money to go towards reducing overdose deaths	285
Increasing humanitarian concerns for 2023	284
A new era for Africa CDC	282
Changing gloves and switching instruments to decrease surgical site infection in abdominal surgery	282
Realising transformative change in adolescent health and wellbeing: a second Lancet Commission	282
床前孝子	281
Use the remaining carbon budget wisely for health equity and climate justice	280
Anna Gilmore: confronting the commercial determinants of health	279
Mortality during migration through the Darién Gap in Panama in 2018–22	278
Offline: “I have no place to go”	276
Anthony Bryceson	275
Annabel Sowemimo: countering inequities in health care	274
Department of Error	273
Can COVID-19 help accelerate and transform the diagnostics agenda?	273
Immediate versus delayed sequential bilateral cataract surgery	271
Department of Error	271
Nigeria's National Mental Health Act 2021: any challenges ahead?	270
US plan to shield science from “inappropriate influence”	268
The health dimensions of violence in Palestine: a call to prevent genocide	264
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, random	264
Protein provision during critical illness	262
Perilous two-tier COVID-19 global vaccine roll-out	255
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use	254
“It's not about us anymore”: after the Le Scouarnec case	251
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi	250
Resurgence of cholera amidst ongoing war in Sudan	247
The injustice of tuberculosis	247

Atosiban and managing women in preterm labour	246
Prioritising maternal health must include care before pregnancy	245
Merrill Singer	245
Improving children's lives—the case for universality	245
Can the FDA fulfil its mission with a smaller workforce?	242
CAR T-cell perspectives in lupus – Authors' reply	240
“I'm losing faith in everything”: a qualitative study to understand barriers to accessing suitable mental health support for children and young people in Wales	240
The 2024 Lasker Awards	239
Pivotal points in the science of dementia risk reduction	239
Delayed immune tolerance through donor haematopoietic stem cell infusion 14 months after kidney transplantation	238
Malaria vaccines: a test for global health	238
Breaking dependency: strengthening the global tuberculosis response in the face of USAID cuts	238
Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlle	237
Mpox: the need for a coordinated international response	236
Childhood epilepsy	236
Orbital atherectomy for stent implantation: the ECLIPSE trial – Authors' reply	234
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study	234
Offline: The unavoidable reckoning	234
Sanctions and the right to health in post-Assad Syria	234
Colonoscopy versus faecal immunochemical testing in COLONPREV	233
Health and development from preconception to 20 years of age and human capital	232
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial	231
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised control	229
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial	228
Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches	228
Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial	227
South Korean doctors threaten mass resignation	226
Report of the Lancet Commission on the Value of Death: bringing death back into life	226
The pathogenesis of Parkinson's disease	224
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes	223
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Bur	222
Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial	221
Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: an evidence review and modelling analysis	221
Shakuntala Thilsted: shifting our approach to food systems	217
Clopidogrel use in chronic coronary syndrome: a fragile lifelong choice	217
The USA and the plight of children in a humanitarian crisis	215
New EU Health Commissioner appointed amid controversy	215
Androgen deprivation therapy combined with postoperative radiotherapy for prostate cancer management	215
Time to fast-track interventions to road traffic crises in Iran	215
Breastfeeding and the role of the commercial milk formula industry – Authors' reply	214
Accelerating domestic investments to end AIDS in Africa	213
Opening the door to widespread iPSC-derived regenerative therapy for corneal epithelial opacity	211
“Even worse than fentanyls”: nitazenes in the USA	211
An urgent case for measles vaccination in Gaza	211
Protecting the blood donor: ferritin-based intervals to improve donor health	208
Timing of cardiac surgery and anticoagulants after acute ischaemic stroke	207
Infectious diseases in 2025: a year for courage and conviction	204
The structural roots of violence against female health workers	203
Realigning the physical activity research agenda for population health, equity, and wellbeing	203
Libby Sallnow: the gentle disruptor	202
The Health Index: a framework to guide health-driven prosperity	202
Unanswered questions from the IRONMAN trial	200
Kangaroo mother care before stabilisation: the OMWaNA trial	200
Optimal usage of antibacterial sutures for wound closure in clinical trials addressing SSI – Authors' response	199
The effect of tranexamic acid on postpartum bleeding in women with moderate and severe anaemia (WOMAN-2): an international, randomised, double-blind, placebo-controlled trial	199
Rethinking research and generative artificial intelligence	199
Mechanical circulatory support for cardiogenic shock	198
Matching actions to needs: shifting policy responses to the changing health needs of Chinese children and adolescents	198
Recommitting to global solidarity: introducing the Kigali Call to Action	195
Calls for the Olympics to end harmful Coca-Cola sponsorship	195
Racism and the health system	194
Why aren't the Republicans talking about health?	193
The R21/Matrix-M malaria vaccine: questions remain	191
Public health and gun violence	190
Department of Error	188
Department of Error	188
Major change in Polish public IVF funding	185
Loiasis: bringing an end to neglect	185
Antimicrobial resistance in carceral settings	184
Warnings over misuse of psychiatry in Russia	183
Seizure-induced apnoea and the risk of sudden unexpected death in epilepsy	182
Hospitals as tenants: the rise of real estate investment trusts in health-care delivery	182
On going backwards	182
Private actors and governance for planetary health equity	181
Efficacy of typhoid conjugate vaccine in Malawian children – Authors’ reply	181
Assessing worldwide trends of underweight and obesity – Authors' reply	178
Emodepside against hookworm	177
Assessing worldwide trends of underweight and obesity	177
Refugees and asylees with disabilities: a call for economic integration	177
Wolves and women's bodies	175
Therapeutic vaccines for Epstein–Barr virus: a way forward	174
Global HIV targets: a roadmap to 2030 and beyond	174
Investing in adolescent health and wellbeing to secure sustainable progress	174
Can we turn the tide on NCDs in 2025?	173
Opioids for back and neck pain: the OPAL trial	173
American chaos: standing up for health and medicine	172
The nuclear threat: policy, science, and public opinion	172
Long-term efficacy and public health implications of the Vi-tetanus toxoid conjugate vaccine in Bangladeshi children	171
Offline: Help us, please	171
Ticagrelor monotherapy for acute coronary syndromes – Authors' reply	170
Traditional Chinese medicine for acute intracerebral haemorrhage	170
Broken promises: the USA foreign aid freeze threatens women's, children's, and adolescents' health	169
How do homeless service users view their own health and healthcare? An ethnographic study	169
Assessing adherence to Government's sugar, salt, and calorie reduction targets of the top 20 UK restaurants' menus in 2024: a cross-sectional study	169
Co-production of a stakeholder workshop to inform multimorbidity prevention research: working with public contributors to ask the right questions (the MELD-B experience)	168